Cancer History ProjectConversation with The Cancer LetterFree Kay Dickersin: How NBCC started Project LEAD to teach science to breast cancer patients January 13, 2023Vol.49 No.02By Alexandria Carolan
Conversation with The Cancer Letter What Ruben Mesa is thinking as he steps into one of the most-watched jobs in cancer January 06, 2023Vol.49 No.01By Paul Goldberg
Conversation with The Cancer LetterFree NCI Director Monica Bertagnolli has breast cancer“I have more motivation to get up every morning to keep doing what I do” December 14, 2022Vol.48 No.45By Paul Goldberg and Matthew Bin Han Ong
Conversation with The Cancer Letter FDA’s Singh and Rivera describe the “new normal”—and the future—in cancer pragmatic trials December 09, 2022Vol.48 No.44By Jacquelyn Cobb, Matthew Bin Han Ong and Paul Goldberg
Conversation with The Cancer Letter Roy Herbst: I hope Pragmatica-Lung will become the norm December 02, 2022Vol.48 No.43By Jacquelyn Cobb and Paul Goldberg
Conversation with The Cancer Letter Ellen Sigal: Pragmatica-Lung may be a model for other trials that are unnecessarily complex December 02, 2022Vol.48 No.43By Matthew Bin Han Ong
Conversation with The Cancer Letter Joseph Califano named director of UCSD Moores Cancer Center November 18, 2022Vol.48 No.42By Paul Goldberg
Conversation with The Cancer Letter Nature Medicine paper confirms clinical utility of liquid biopsies in routine care for lung cancerCohort study finds significant OS benefit in NSCLC with targetable ctDNA alterations November 18, 2022Vol.48 No.42By Matthew Bin Han Ong
Conversation with The Cancer Letter NCI’s Doroshow: “These recommendations are something that we can implement right away” November 11, 2022Vol.48 No.41By Paul Goldberg
Cancer History ProjectConversation with The Cancer LetterFree Craig Jordan on discovering tamoxifen’s role in breast cancer—and a lifetime of innovation November 11, 2022Vol.48 No.41By Alexandria Carolan
